Longhorn Vaccines and Diagnostics Presents New Preclinical Data on Broad-Spectrum Anti-Bacterial Monoclonal Antibody LHNVD-501

Press Release
Written By Van Agens
Van Agens
Previous

Longhorn Vaccines and Diagnostics to Present New Data on DRG5‑BD11 Showing Broad Activity Against Multiple Bacterial Classes at ESCMID 2026
Next

Longhorn Vaccines & Diagnostics' PrimeStore® MTM Validated with New Data for Large-Scale, Global TB Screening